Dr. Josh Woolley

Psychedelic drug discovery company Filament Health Corp. (OTCQB: FLHLF) (NEO: FH) obtained FDA approval to start the first clinical trial using naturally-sourced psychedelic substances.   Filament revealed that this authorization is the first for the direct administration of psilocin,...